II Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland
Cancer Prevention Department, Center de Lutte Contre le Cancer Léon Bérard, Lyon, France.
Int J Gynecol Cancer. 2024 Sep 2;34(9):1324-1333. doi: 10.1136/ijgc-2024-005844.
The 'Best of ESGO 2024' article includes a selection of the most highly rated original research presented during the 25th Annual Congress of the European Society of Gynaecologic Oncology (ESGO), held in Barcelona, Spain, March 7-10, 2024. Of 1218 asbtracts submitted, 35 studies presented during the best oral sessions, mini oral sessions, best three minute presentations session, and young investigator session were selected by the ESGO abstract committee and the authors of the European Network of Young Gynae Oncologists (ENYGO). There was a strong focus on the surgical treatment of early stage cervical cancer and the management of advanced or recurrent gynecological cancers using induction therapy, immunotherapy, and maintenance therapy. With this work, ENYGO and ESGO aim to focus the attention of clinicians, scientists, patients, and all stakeholders interested in gynecologic oncology on research advances in the field.
“2024 年 ESGO 精选”一文包含在西班牙巴塞罗那举行的第 25 届欧洲妇科肿瘤学会（ESGO）年会期间提交的最受好评的原创研究精选，2024 年 3 月 7 日至 10 日。在提交的 1218 份摘要中，ESGO 摘要委员会和欧洲青年妇科肿瘤学家网络（ENYGO）的作者选择了在最佳口头会议、迷你口头会议、最佳三分钟演讲会议和青年研究员会议上提交的 35 项研究。重点是早期宫颈癌的手术治疗以及使用诱导治疗、免疫治疗和维持治疗治疗晚期或复发性妇科癌症。通过这项工作，ENYGO 和 ESGO 旨在将临床医生、科学家、患者和所有对妇科肿瘤学感兴趣的利益相关者的注意力集中在该领域的研究进展上。
